Insider · CIK 0001705492
Alan R. Stewart
Files at SSTI (SOUNDTHINKING, INC.), CLDI (Calidi Biotherapeutics, Inc.). First filing Dec 12, 2024, latest Dec 12, 2024.
In brief
Alan R. Stewart files SEC Form 4 as director and CFO at SSTI (SOUNDTHINKING, INC.), and also at CLDI (Calidi Biotherapeutics, Inc.). Since Dec 12, 2024, Alan R. Stewart has reported 0 open-market buys worth $0 and 1 open-market sell worth $209k, the latest filed on Dec 12, 2024.
A track record needs three past buys with six months of prices behind them; Alan R. Stewart has 0, so none is measured yet.
The newest scored trade: sold $209k of SSTI on Dec 10, 2024, filed Dec 12, 2024, scored 49 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SSTI: SOUNDTHINKING, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | SOUNDTHINKING, INC. | $209k 15,000 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 28, 2025 | SSTI SOUNDTHINKING, INC. | 5,000 0.04% of outstanding | $81k | Feb 28, 2025 | $209k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +4,000 | $0.00 | $0 | 4,000 | Aug 19, 2026 |
| May 19, 2026 | SSTI SOUNDTHINKING, INC. | AGrant or award Common Stock | +74,963 | $0.00 | $0 | 245,126 | May 21, 2026 |
| Jul 9, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +137,078 | $0.00 | $0 | 137,078 | Jul 15, 2025 |
| Dec 31, 2024 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Common Stock | +12,771 | - | - | 28,976 | Jan 3, 2025 |
| Dec 10, 2024 | SSTI SOUNDTHINKING, INC. | SOpen-market sale Common Stock | -15,000 | $13.95 | $209k | 138,851 | Dec 12, 2024 |
| Sep 20, 2024 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +20,217 | - | - | 20,217 | Oct 15, 2024 |
Questions about Alan R. Stewart
Answered from the filings on this page, as of the latest one.
Is Alan R. Stewart buying or selling?
Not in the last 12 months. Alan R. Stewart's latest open-market trade on SEC Form 4 was sold $209k of SSTI on Dec 10, 2024.
How did Alan R. Stewart's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan R. Stewart has 0.
Where does Alan R. Stewart file Form 4?
Alan R. Stewart has filed Form 4 at SSTI (SOUNDTHINKING, INC.) as Chief Financial Officer; CLDI (Calidi Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.